Delivery Order SPE2DE24DA017-SPE2D625F2FKT
Award Date 8/29/25
Potential Completion Date 9/4/25
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $3,029.40 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the ACP MAX PRP System with ACDA. The delivery order, which is not set-aside for any specific business category, has an ultimate completion date of July 29, 2025, and will be performed in Naples, Florida. This award represents a task order under Arthrex's broader Indefinite...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,029.40 on August 27, 2025, for the ACP MAX PRP System with ACDA (autologous conditioned plasma). This fixed-price delivery order with economic price adjustment is scheduled for completion by September 2, 2025, and represents performance under Arthrex's larger indefinite delivery contract with the Defense Logistics Agency's Medical Supply Chain. The order...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,111.90 on August 22, 2025, under a fixed-price contract with economic price adjustment provisions. The order, identified as 4569186034 and titled "ACP MAX PRP SYSTEM (W/ ACDA)," is scheduled for completion by August 27, 2025, with performance to be executed in Naples, Florida. This delivery order was issued without a set-aside designation, reflecting...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,960 delivery order to Arthrex Inc. on August 21, 2025, for the ACP MAX PRP System (OUS/EU). This fixed-price contract with economic price adjustment represents task order activity under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and spanning June 2024 through September 2029. The delivery order is not designated as a set-aside and is scheduled for...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,633.30, is a Delivery Order for an "ACP MAX PRP SYSTEM (W/ ACDA)" and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 9, 2025. The contract was not designated as a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a leading developer of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a fixed-price delivery order valued at $25,122.10 by the Defense Logistics Agency's Medical Supply Chain. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, calls for the delivery of an ACD-A 13G Open Tip BMA Angel Kit—a specialized orthopedic surgical product related to Arthrex's ANGEL platelet-rich plasma (PRP) system. The...